Disclosed is a felbinac-containing transdermal absorption preparation substantially free of felbinac solubilizer in the final formulation, but still having a high level of felbinac release. In particular is disclosed an adhesive patch which contains a combination of lidocaine and felbinac and which has high level of felbinac release without sacrificing the release level of lidocaine. The felbinac-containing transdermal absorption adhesive patch contains felbinac as an active ingredient, and lidocaine or a pharmaceutically acceptable salt thereof as a sorbefacient. In particular, the felbinac is 0.1-10 wt% of the entire drug-containing ointment, and the lidocaine or pharmaceutically acceptable salt thereof is 0.01-20 wt% of the entire drug-containing ointment.
